- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alectinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alectinibmarket, defines the market attractiveness level of Alectinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alectinib industry, describes the types of Alectinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alectinib market and the development prospects and opportunities of Alectinib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alectinib market in Chapter 13.
By Player:
Roche
Everest Pharmaceuticals
By Type:
150mg*140 Capsules
150mg*28 Capsules
20mg*1 Capsule
40mg*1 Capsule
150mg*26 Capsules
By End-User:
Unresectable NSCLC
Advanced NSCLC
Recurrent NSCLC
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alectinib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alectinib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alectinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alectinib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alectinib Market Analysis and Outlook to 2022
-
7.1 Global Alectinib Consumption (2017-2022)
-
7.2 United States Alectinib Consumption (2017-2022)
-
7.3 Europe Alectinib Consumption (2017-2022)
-
7.4 China Alectinib Consumption (2017-2022)
-
7.5 Japan Alectinib Consumption (2017-2022)
-
7.6 India Alectinib Consumption (2017-2022)
-
7.7 South Korea Alectinib Consumption (2017-2022)
8 Region and Country-wise Alectinib Market Analysis and Outlook to 2028
-
8.1 Global Alectinib Consumption Forecast (2022-2028)
-
8.2 United States Alectinib Consumption Forecast (2022-2028)
-
8.3 Europe Alectinib Consumption Forecast (2022-2028)
-
8.4 China Alectinib Consumption Forecast (2022-2028)
-
8.5 Japan Alectinib Consumption Forecast (2022-2028)
-
8.6 India Alectinib Consumption Forecast (2022-2028)
-
8.7 South Korea Alectinib Consumption Forecast (2022-2028)
9 Global Alectinib Market Outlook by Types and Applications to 2022
-
9.1 Global Alectinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 150mg*140 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 150mg*28 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 20mg*1 Capsule Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 40mg*1 Capsule Consumption and Growth Rate (2017-2022)
-
9.1.5 Global 150mg*26 Capsules Consumption and Growth Rate (2017-2022)
-
9.2 Global Alectinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Unresectable NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Advanced NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Recurrent NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Alectinib Market Outlook by Types and Applications to 2028
-
10.1 Global Alectinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 150mg*140 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 150mg*28 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 20mg*1 Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 40mg*1 Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global 150mg*26 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alectinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Unresectable NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Advanced NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Recurrent NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Alectinib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alectinib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alectinib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alectinib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alectinib Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Alectinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Alectinib Product and Service
-
14.2 Everest Pharmaceuticals
-
14.2.1 Everest Pharmaceuticals Company Details
-
14.2.2 Everest Pharmaceuticals Alectinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Everest Pharmaceuticals Alectinib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alectinib
-
Figure Alectinib Picture
-
Table Global Alectinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alectinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alectinib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alectinib Consumption by Country (2017-2022)
-
Figure United States Alectinib Consumption and Growth Rate (2017-2022)
-
Table Europe Alectinib Consumption and Growth Rate (2017-2022)
-
Figure China Alectinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Alectinib Consumption and Growth Rate (2017-2022)
-
Figure India Alectinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alectinib Consumption and Growth Rate (2017-2022)
-
Figure Global Alectinib Consumption Forecast by Country (2022-2028)
-
Figure United States Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg*140 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg*28 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 20mg*1 Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global 40mg*1 Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg*26 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Unresectable NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Advanced NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Recurrent NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg*140 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg*28 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 20mg*1 Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40mg*1 Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg*26 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Unresectable NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Advanced NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recurrent NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alectinib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alectinib Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Alectinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Alectinib Product and Service
-
Table Everest Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Everest Pharmaceuticals Alectinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Everest Pharmaceuticals Alectinib Product and Service
-